115 related articles for article (PubMed ID: 35952503)
21. Combined effects of GSTP1 and MRP1 in melanoma drug resistance.
Depeille P; Cuq P; Passagne I; Evrard A; Vian L
Br J Cancer; 2005 Jul; 93(2):216-23. PubMed ID: 15999103
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor.
Okamura T; Singh S; Buolamwini J; Haystead T; Friedman H; Bigner D; Ali-Osman F
J Biol Chem; 2009 Jun; 284(25):16979-16989. PubMed ID: 19254954
[TBL] [Abstract][Full Text] [Related]
23. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
Singal R; van Wert J; Bashambu M
Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
[TBL] [Abstract][Full Text] [Related]
24. Implications of glutathione-S transferase P1 in MAPK signaling as a CRAF chaperone: In memory of Dr. Irving Listowsky.
Niitsu Y; Sato Y; Takayama T
Proc Jpn Acad Ser B Phys Biol Sci; 2022; 98(2):72-86. PubMed ID: 35153270
[TBL] [Abstract][Full Text] [Related]
25. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus.
Wang T; Arifoglu P; Ronai Z; Tew KD
J Biol Chem; 2001 Jun; 276(24):20999-1003. PubMed ID: 11279197
[TBL] [Abstract][Full Text] [Related]
26. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
Diah SK; Smitherman PK; Townsend AJ; Morrow CS
Toxicol Appl Pharmacol; 1999 Jun; 157(2):85-93. PubMed ID: 10366541
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.
Sawers L; Ferguson MJ; Ihrig BR; Young HC; Chakravarty P; Wolf CR; Smith G
Br J Cancer; 2014 Sep; 111(6):1150-8. PubMed ID: 25010864
[TBL] [Abstract][Full Text] [Related]
28. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1.
Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D
Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
[TBL] [Abstract][Full Text] [Related]
30. Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.
Kanwal R; Pandey M; Bhaskaran N; Maclennan GT; Fu P; Ponsky LE; Gupta S
Mol Carcinog; 2014 Jan; 53(1):8-18. PubMed ID: 22833520
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes.
Ranganathan PN; Whalen R; Boyer TD
Biochem J; 2005 Mar; 386(Pt 3):525-33. PubMed ID: 15471539
[TBL] [Abstract][Full Text] [Related]
32. A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1).
Crawford LA; Weerapana E
Mol Biosyst; 2016 May; 12(6):1768-71. PubMed ID: 27113843
[TBL] [Abstract][Full Text] [Related]
33. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
34. Glutathione analogues as substrates or inhibitors that discriminate between allozymes of the MDR-involved human glutathione transferase P1-1.
Zompra A; Georgakis N; Pappa E; Thireou T; Eliopoulos E; Labrou N; Cordopatis P; Clonis Y
Biopolymers; 2016 May; 106(3):330-44. PubMed ID: 27037874
[TBL] [Abstract][Full Text] [Related]
35. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
36. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer.
Berendsen CL; Mulder TP; Peters WH
J Urol; 2000 Dec; 164(6):2126-8. PubMed ID: 11061940
[TBL] [Abstract][Full Text] [Related]
37. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents.
Bräutigam M; Teusch N; Schenk T; Sheikh M; Aricioglu RZ; Borowski SH; Neudörfl JM; Baumann U; Griesbeck AG; Pietsch M
ChemMedChem; 2015 Apr; 10(4):629-39. PubMed ID: 25694385
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic studies of inactivation of glutathione S-transferase Pi isozyme by a haloenol lactone derivative.
Zheng J; Liu G; Tozkoparan B; Wen D
Med Chem; 2005 Mar; 1(2):191-8. PubMed ID: 16787314
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition.
Zhao G; Yu T; Wang R; Wang X; Jing Y
Bioorg Med Chem; 2005 Jun; 13(12):4056-62. PubMed ID: 15911318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
